Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
GSK plc

Start price
Target price
Perf. (%)
€16.86
17.06.21
-
17.06.25
0.47%
05.07.21

Small cyclical dependencies
Could be worthwhile Investment >10% per year
Gilbert 
17.06.21 50%
sell
Valneva SE

Start price
Target price
Perf. (%)
€10.89
17.06.21
€8.00
17.06.22
3.21%
20.07.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
melinda 
17.06.21 50%
sell
Avid Bioservices Inc

Start price
Target price
Perf. (%)
€20.60
17.06.21
€17.00
17.06.22
38.84%
26.11.21

Could be worthwhile Investment >10% per year
melinda 
17.06.21 50%
sell
Carisma Therapeutics Inc.

Start price
Target price
Perf. (%)
€73.80
17.06.21
€50.00
17.06.22
-66.50%
17.08.21

Could be worthwhile Investment >10% per year
melinda 
17.06.21 50%
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€46.95
16.06.21
€75.00
16.06.22
2.24%
28.06.21

Fair valuation
Good rating
Normal challenges to pay loans and raise capital
Leading role in innovation
DomRuinart 
16.06.21 50%
buy
Novartis AG ADR

Start price
Target price
Perf. (%)
€77.60
15.06.21
-
15.06.24
19.07%
11.03.24

Could be worthwhile Investment >10% per year
Lutz69 
15.06.21 50%
sell
Novan Inc

Start price
Target price
Perf. (%)
€15.74
14.06.21
-
14.06.22
-40.72%
17.06.21

Risky Investment
tinelchen 
14.06.21 0%
buy
Cocrystal Pharma Inc.

Start price
Target price
Perf. (%)
€13.20
14.06.21
€24.00
14.06.22
0.00%
26.06.21

Could be worthwhile Investment >10% per year
Good culture
Little innovation
me8 
14.06.21 0%
buy
Avid Bioservices Inc

Start price
Target price
Perf. (%)
€19.30
14.06.21
€22.00
14.06.22
6.74%
17.06.21

Could be worthwhile Investment >10% per year
melinda 
14.06.21 50%
sell
CytRx Corp.

Start price
Target price
Perf. (%)
€2.50
13.06.21
-
13.06.22
-66.00%
27.06.21

Risky Investment
daimler1 
13.06.21 50%
buy
Novan Inc

Start price
Target price
Perf. (%)
€12.12
12.06.21
-
12.06.22
-81.58%
13.06.22

Could be worthwhile Investment >10% per year
skyrockerZoe 
12.06.21 0%
buy
CytRx Corp.

Start price
Target price
Perf. (%)
€2.50
12.06.21
-
12.06.22
-95.75%
13.06.22

Could be worthwhile Investment >10% per year
skyrockerZoe 
12.06.21 0%
buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€10.12
12.06.21
€25.00
12.06.22
-70.64%
13.06.22

Could be very worthwhile Investment >20% year
skyrockerZoe 
12.06.21 0%
buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€3.22
11.06.21
€4.00
11.06.22
-69.57%
14.12.21

Could be worthwhile Investment >10% per year
melinda 
11.06.21 50%
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€18.77
11.06.21
€23.20
11.06.22
-14.32%
24.06.21

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
geldnutzer 
11.06.21 50%
buy
Galapagos N.V.

Start price
Target price
Perf. (%)
€65.08
09.06.21
€70.00
09.06.22
-30.73%
13.10.21

Could be worthwhile Investment >10% per year
melinda 
09.06.21 50%
buy
Invitae Corp

Start price
Target price
Perf. (%)
€25.10
09.06.21
€30.00
09.06.22
-89.88%
10.06.22

Could be worthwhile Investment >10% per year
melinda 
09.06.21 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€320.85
08.06.21
€330.00
08.06.22
-41.88%
08.06.22

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Top 10 in its market
Well known brand
tbackenh 
08.06.21 80%
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€38.32
07.06.21
€48.00
07.06.22
4.12%
21.06.21

Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Little Investments for future growth
Mori8 
07.06.21 50%
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€91.61
03.06.21
€115.00
03.06.22
34.21%
04.06.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
ValueFreak 
03.06.21 80%
buy
Bayer AG

Start price
Target price
Perf. (%)
€52.22
03.06.21
-
03.06.22
-2.82%
26.02.22

Revenue growth > 30% per year expected
Undervalued
High Investments for future growth
Top Rating
Maleri 
03.06.21 50%
buy
Haemato AG

Start price
Target price
Perf. (%)
€29.20
31.05.21
-
31.05.24
-36.99%
11.03.24

Could be worthwhile Investment >10% per year
Lutz69 
31.05.21 50%
buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.74
31.05.21
€15.00
31.05.22
-60.61%
01.06.22

Fair valuation
Strong uniques
Leading role in innovation
Bad rating
skatcup 
31.05.21 80%
buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€2.18
31.05.21
€4.00
31.05.22
4.59%
14.06.21

Could be worthwhile Investment >10% per year
DomRuinart 
31.05.21 50%
buy
Ziopharm Oncology

Start price
Target price
Perf. (%)
€2.44
31.05.21
€4.00
31.05.22
-2.46%
07.06.21

Could be worthwhile Investment >10% per year
DomRuinart 
31.05.21 50%